Alexandra Emile-Reynolds

Alexandra Emile-Reynolds,

Clinical Research Coord I

Department: MD-GASTROENTEROLOGY
Business Phone: (352) 273-9483
Business Email: aemile@ufl.edu

Grants

May 2024 ACTIVE
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Risankizumab Subcutaneous Induction Treatment in Subjects with Moderately to Severely Active Crohn's Disease
Role: Other
Funding: ABBVIE

Contact Details

Phones:
Business:
(352) 273-9483
Emails:
Business:
aemile@ufl.edu
Addresses:
Business Mailing:
PO Box 100214
GAINESVILLE FL 32610